Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro
- PMID: 7509101
- DOI: 10.1530/acta.0.1290565
Production of alpha-subunit of glycoprotein hormones by pituitary somatotroph adenomas in vitro
Abstract
Somatotroph adenomas of the pituitary secrete growth hormone in excess and are associated with acromegaly. Morphologically, they can be separated into two entities, densely and sparsely granulated variants. It has been shown that a number of somatotroph adenomas produce alpha-subunit of glycoprotein hormones; however, it is not clear whether alpha-subunit production correlates with tumor cell morphology. We studied 32 surgically removed pituitary somatotroph adenomas in tissue culture to determine structure-function correlations of growth hormone and alpha-subunit production. All tumors were classified on the basis of detailed histological, immunocytochemical and electron-microscopic studies. Fifteen tumors were densely granulated and 17 were sparsely granulated. In addition to growth hormone, all 15 densely granulated tumors released alpha-subunit in vitro, whereas of the 17 sparsely granulated tumors only 4 released alpha-subunit; moreover, the mean baseline levels of alpha-subunit were significantly higher in densely granulated adenomas than in sparsely granulated adenomas. Parallel response of release of both hormones was found during stimulation with growth hormone-releasing hormone or thyrotropin-releasing hormone and during suppression with somatostatin or bromocriptine in densely granulated tumors. alpha-subunit response to stimulation or suppression could not be determined with significance in sparsely granulated tumors because of low basal levels. The results indicate that alpha-subunit production and release is characteristic of densely granulated somatotroph adenomas and that alpha-subunit is coregulated with growth hormone by adenohypophysiotropic substances; in contrast, alpha-subunit production, by sparsely granulated somatotroph adenomas is rare and, when present, much lower in quantity.(ABSTRACT TRUNCATED AT 250 WORDS)
Comment in
-
Effects of long-term estradiol exposure on the hypothalamic neuron number.Acta Endocrinol (Copenh). 1993 Dec;129(6):543-7. doi: 10.1530/acta.0.1290543. Acta Endocrinol (Copenh). 1993. PMID: 8109189
Similar articles
-
Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.Neurosurgery. 1993 Jul;33(1):20-7. doi: 10.1227/00006123-199307000-00003. Neurosurgery. 1993. PMID: 7689191
-
Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation.J Endocrinol Invest. 1989 Jul-Aug;12(7):443-48. doi: 10.1007/BF03350727. J Endocrinol Invest. 1989. PMID: 2551950
-
Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.Virchows Arch A Pathol Anat Histopathol. 1993;422(3):193-201. doi: 10.1007/BF01621802. Virchows Arch A Pathol Anat Histopathol. 1993. PMID: 8493775
-
Pathology of acromegaly.Neuroendocrinology. 2006;83(3-4):161-5. doi: 10.1159/000095524. Epub 2006 Oct 13. Neuroendocrinology. 2006. PMID: 17047379 Review.
-
Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.Eur J Endocrinol. 2007 Feb;156(2):203-16. doi: 10.1530/eje.1.02326. Eur J Endocrinol. 2007. PMID: 17287410 Review.
Cited by
-
Plurihormonality in pituitary adenomas associated with acromegaly.Endocr Pathol. 2006 Fall;17(3):291-6. doi: 10.1385/ep:17:3:291. Endocr Pathol. 2006. PMID: 17308366
-
Pathologic Characteristics of Somatotroph Pituitary Tumors-An Observational Single-Center Study.Biomedicines. 2023 Dec 15;11(12):3315. doi: 10.3390/biomedicines11123315. Biomedicines. 2023. PMID: 38137536 Free PMC article.
-
Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.J Endocrinol Invest. 1999 Oct;22(9):671-80. doi: 10.1007/BF03343628. J Endocrinol Invest. 1999. PMID: 10595830
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical